“Elixir” DESyne X2 Novolimus Eluting Coronary Stent System - Taiwan Registration 1a89a125d7449668a1c14783d5884c03
Access comprehensive regulatory information for “Elixir” DESyne X2 Novolimus Eluting Coronary Stent System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number 1a89a125d7449668a1c14783d5884c03 and manufactured by Elixir Medical Corporation;;Acon Regulatory Consultancy Services Ltd. The authorized representative in Taiwan is CLOVERS BIOTECHNOLOGY CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
1a89a125d7449668a1c14783d5884c03
Ministry of Health Medical Device Import No. 031833
DHA05603183300
Product Details
For details, it is Chinese approved copy of the imitation order
E Cardiovascular devices
E0001 Cardiovascular stents
Imported from abroad; Contract manufacturing
Dates and Status
Oct 10, 2018
Oct 10, 2028

